Volume 74, Issue 5, Pages (November 2018)

Slides:

Advertisements

Similar presentations

Volume 50, Issue 3, Pages (September 2006)

Advertisements

Management of Phantom Pain with a Textile, Electromagnetically-Acting Stump Liner: A Randomized, Double-Blind, Crossover Study Uwe Kern, MD, Bernd Altkemper,

Volume 52, Issue 1, Pages (July 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Patient-Reported Outcomes as a Component of the Primary Endpoint in a Double-Blind, Placebo-Controlled Trial in Advanced Pancreatic Cancer S. Gail Eckhardt,

Contemporary Management of the Painful Bladder: A Systematic Review

Volume 64, Issue 5, Pages (November 2013)

Volume 54, Issue 6, Pages (December 2008)

Volume 72, Issue 5, Pages (November 2017)

Volume 50, Issue 5, Pages (November 2006)

Volume 66, Issue 6, Pages (December 2014)

Volume 52, Issue 2, Pages (August 2007)

Let the Games Begin (with EAU Approval)

Prostate Cancer Epidemic in Sight?

John P. Mulhall, Francesco Montorsi European Urology

Volume 53, Issue 2, Pages (February 2008)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 59, Issue 3, Pages (March 2011)

Back to the Future: Introduction and Conclusions

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Volume 52, Issue 3, Pages (September 2007)

Volume 62, Issue 3, Pages (September 2012)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Prostate Cancer Detection: A View of the Future

Short-term placebo response in trials of patients with symptomatic osteoarthritis: differences between hip and knee S. Reiter-Niesert, M. Boers, J. Detert

Low-risk Prostate Cancer: Identification, Management, and Outcomes

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old P. Perrin,

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.

The Economic Costs of Overactive Bladder in Germany

Volume 48, Issue 6, Pages (December 2005)

Volume 50, Issue 5, Pages (November 2006)

Volume 46, Issue 5, Pages (November 2004)

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized,

Volume 51, Issue 1, Pages (January 2007)

Pre-Emptive Value of Methylprednisolone Intravenous Infusion in Patients With Vertebral Metastases. A Double-Blind Randomized Study Ayman Abd Al-maksoud.

Double-Blind, Placebo-Controlled Trial of Lamotrigine in Combination with Other Medications for Neuropathic Pain Marianne Silver, MS, David Blum, MD,

Hooman Djaladat, Parvin Tajik, Pooya Payandemehr, Sara Alehashemi

A randomized, double-blind, crossover study of the use of transcutaneous spinal electroanalgesia in patients with pain from chronic critical limb ischemia

Gastrointestinal Effects of NSAIDs and Coxibs

Testicular Cancer Variations in Time and Space in Europe

Lack of Benefit From Paracetamol (Acetaminophen) for Palliative Cancer Patients Requiring High-Dose Strong Opioids: A Randomized, Double-Blind, Placebo-Controlled,

Volume 72, Issue 5, Pages (November 2017)

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized,

Volume 53, Issue 6, Pages (June 2008)

Christian Stief European Urology Supplements

European Urology is “Your” Journal

A Proposed Taxonomy of Terms to Guide the Clinical Trial Recruitment Process Neil A. Hagen, MD, FRCPC, Jackson S. Wu, MD, FRCPC, Carla R. Stiles, BN

A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee

Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study G.

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Volume 55, Issue 3, Pages (March 2009)

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia? Vincenzo Mirone

Armodafinil for Sarcoidosis-Associated Fatigue: A Double-Blind, Placebo-Controlled, Crossover Trial Elyse E. Lower, MD, Atul Malhotra, MD, Victoria Surdulescu,

Randomized, Double-Blind, Placebo-Controlled Trial of Oral Docusate in the Management of Constipation in Hospice Patients Yoko Tarumi, MD, Mitchell P.

Volume 121, Issue 5, Pages (November 2001)

Double-blind, randomized, placebo-controlled trial comparing rofecoxib with dexketoprofen trometamol in surgical dentistry Jackson I.D. , Heidemann B.H.

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Management of Phantom Pain with a Textile, Electromagnetically-Acting Stump Liner: A Randomized, Double-Blind, Crossover Study Uwe Kern, MD, Bernd Altkemper,

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 74, Issue 5, Pages 623-630 (November 2018) A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome Philip C. Bosch European Urology Volume 74, Issue 5, Pages 623-630 (November 2018) DOI: 10.1016/j.eururo.2018.07.026 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 Study design and patient allocation. GRA=Global Response Assessment; ICPI=Interstitial Cystitis Problem Index; ICSI=Interstitial Cystitis Symptom Index; SQ=subcutaneous. European Urology 2018 74, 623-630DOI: (10.1016/j.eururo.2018.07.026) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 2 Change from baseline in secondary outcome measures comparing certolizumab pegol with placebo. ICPI=Interstitial Cystitis Problem Index; ICSI=Interstitial Cystitis Symptom Index. European Urology 2018 74, 623-630DOI: (10.1016/j.eururo.2018.07.026) Copyright © 2018 European Association of Urology Terms and Conditions